These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2240475)

  • 1. A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo MD; Ruccione KS; Krivit WA; Hammond GD
    Am J Pediatr Hematol Oncol; 1990; 12(3):301-5. PubMed ID: 2240475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo M; Ruccione KS; Krivit W; Hammond GD
    J Neurooncol; 1990 Aug; 9(1):69-76. PubMed ID: 2213117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.
    Castleberry RP; Ragab AH; Steuber CP; Kamen B; Toledano S; Starling K; Norris D; Burger P; Krischer JP
    Invest New Drugs; 1990 Nov; 8(4):401-6. PubMed ID: 2084075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
    Ettinger LJ; Krailo M; Ruccione KS; Krivit W; Hammond GD
    Am J Pediatr Hematol Oncol; 1988; 10(1):18-22. PubMed ID: 3189713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
    Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
    Falletta JM; Cushing B; Lauer S; Bell B; Mahoney DH; Castleberry R; Krance RA
    Invest New Drugs; 1990 May; 8(2):167-70. PubMed ID: 2384303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; Look K; Anderson B
    Invest New Drugs; 1991 May; 9(2):207-8. PubMed ID: 1874603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
    Eagan RT; Dinapoli RP; Cascino TL; Scheithauer B; O'Neill BP; O'Fallon JR
    J Neurooncol; 1987; 5(4):309-14. PubMed ID: 3440875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
    Chamberlain MC; Prados MD; Silver P; Levin VA
    J Neurooncol; 1988 Dec; 6(4):319-23. PubMed ID: 3221259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Meyers PA; Tan CT; Steinherz PG; Redner A
    Cancer; 1989 Dec; 64(12):2416-9. PubMed ID: 2479459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical evaluation of diaziquone in childhood cancer.
    Ettinger LJ; Siegel SE; Belasco JB; Evans AE; Ruccione KS; Jamin DC; Rohrbaugh TM; Higgins GR
    Cancer Treat Rep; 1985 Mar; 69(3):323-7. PubMed ID: 3856480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
    Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
    J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors.
    Feun LG; Yung WK; Leavens ME; Burgess MA; Obbens EA; Bedikian AY; Savaraj N; Stewart DJ; Benjamin RS; Fields WS
    J Neurooncol; 1984; 2(1):13-7. PubMed ID: 6088722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; Clarke-Pearson D
    Invest New Drugs; 1991 Feb; 9(1):93-4. PubMed ID: 2026490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
    Decker DA; Al Sarraf M; Kresge C; Austin D; Wilner HI
    J Neurooncol; 1985; 3(1):19-21. PubMed ID: 2987424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
    Stephens RL; Kirby R; Crawford ED; Bukowski R; Rivkin SE; O'Bryan RM
    Invest New Drugs; 1986; 4(1):57-9. PubMed ID: 3700042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of diaziquone.
    Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
    Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
    Høst H; Joss R; Pinedo H; Bruntsch U; Cavalli F; Renard G; van Glabbeke M; Rozencweig M
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):295-8. PubMed ID: 6681775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
    Tapazoglou E; Kish J; Ensley J; Al-Sarraf M
    Am J Clin Oncol; 1988 Aug; 11(4):474-8. PubMed ID: 3407628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.